Cargando…

The potential impact of new national guidance on primary prevention of cardiovascular disease in people living with HIV

INTRODUCTION: Cardiovascular disease (CVD) is the leading cause of death in England and Wales. As people living with HIV (PLWH) age, proactive management of CVD risk factors is crucial. The long-awaited draft guidelines for CVD from the National Institute of Clinical Excellence (NICE) propose lipid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Nadia, Bradley, Sarah, Pearson, Patrick, Edwards, Simon, Waters, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P181
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225371/ https://www.ncbi.nlm.nih.gov/pubmed/25397460 http://dx.doi.org/10.7448/IAS.17.4.19713

Ejemplares similares

Quand une pandémie vous fait sortir de vos murs, Oran, Algérie
por: Benissad, S., et al.
Publicado: (2023)

TEP scanner révélant une infection COVID-19 asymptomatique : à propos de 2 cas
por: El Fekak, F.Z., et al.
Publicado: (2021)

Health literacy, source of information and impact on adherence to therapy in people living with HIV
por: Ernst Dorner, Thomas, et al.
Publicado: (2014)

Quality of life of people living with HIV, preliminary results from IANUA (Investigation on Antiretroviral Therapy) study
por: Venturini, Alberto, et al.
Publicado: (2014)

Tackling cardiovascular co-morbidities in HIV-positive patients: who, how and where?
por: Rolls, Sophie, et al.
Publicado: (2014)

Mediterranean diet: the impact on cardiovascular risk and metabolic syndrome in HIV patients, in Lisbon, Portugal
por: Policarpo, Sara, et al.
Publicado: (2014)

Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viraemia
por: Viskovic, Klaudija, et al.
Publicado: (2014)

Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population
por: Thorsteinsson, Kristina, et al.
Publicado: (2014)

Rates of cardiovascular events and deaths are associated with advanced stages of HIV-infection: results of the HIV HEART study 7, 5 year follow-up
por: Esser, Stefan, et al.
Publicado: (2014)

Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitors
por: Barber, Tristan J, et al.
Publicado: (2014)

HIV test: which is your best? A National survey on testing preferences among MSM in Italy
por: Mattioli, Sandro, et al.
Publicado: (2014)

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study
por: Rokx, Casper, et al.
Publicado: (2014)

Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy
por: Bloch, Mark, et al.
Publicado: (2014)

Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor
por: Barber, Tristan, et al.
Publicado: (2014)

Prevalence and concordance of high cardiovascular disease scores in HIV/AIDS patients from Croatia and Serbia with four international algorithms
por: Begovac, Josip, et al.
Publicado: (2014)

Socio-economic factors and virological suppression among people diagnosed with HIV in the United Kingdom: results from the ASTRA study
por: Burch, Lisa, et al.
Publicado: (2014)

Future prospectives of sub-Saharan women living with HIV residing in France for more than seven years: prospective pilot study
por: Dimi, Svetlane, et al.
Publicado: (2014)

Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study
por: Fowler, Nikola, et al.
Publicado: (2014)

Evolution of Framingham cardiovascular risk score in HIV-infected patients initiating EFV- and LPV/r-based HAART in a Latin American cohort
por: Cecchini, Diego, et al.
Publicado: (2014)

Severe birth defects in children perinatal exposed to HIV from a “real-world” setting: Infectious Diseases National Institute, Bucharest, Romania
por: Maria Tudor, Ana
Publicado: (2014)

Effectiveness of the prevention of mother-to-child transmission of HIV protocol applied at Saint Camille Medical Centre in Ouagadougou, Burkina Faso
por: Theophile Soubeiga, Serge, et al.
Publicado: (2014)

Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy
por: Davies, Olubanke, et al.
Publicado: (2014)

OLDER PEOPLE LIVING WITH HIV: THE RELATIONSHIP BETWEEN COMMUNITY-LEVEL FACTORS AND THEIR HIV HEALTH
por: Lee, Yookyong, et al.
Publicado: (2019)

More safer sex intervention needed for HIV-positive MSM with higher education level for prevention of sexually transmitted hepatitis C
por: Wai Chi Lin, Ada, et al.
Publicado: (2014)

Sexual behaviour, recreational drug use and hepatitis C co-infection in HIV-diagnosed men who have sex with men in the United Kingdom: results from the ASTRA study
por: Daskalopoulou, Marina, et al.
Publicado: (2014)

Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification
por: Ruelle, Jean, et al.
Publicado: (2014)

Factors associated with the continuum of care of HIV-infected patients in Belgium
por: Van Beckhoven, Dominique, et al.
Publicado: (2014)

Determinants of HIV outpatient service utilization according to HIV parameters
por: Di Carlo, Paola, et al.
Publicado: (2014)

Transmission route and reasons for HIV testing among recently diagnosed HIV patients in HIV-TR cohort, 2011–2012
por: Dokuzoguz, Basak, et al.
Publicado: (2014)

Uptake of Recommended Vaccines in Pregnancy among People Living with HIV in the United States
por: Berhie, Saba H., et al.
Publicado: (2022)

Loss to follow-up of HIV-infected women after delivery: The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study
por: Aebi-Popp, Karoline, et al.
Publicado: (2014)

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
por: Bianco, Claudia, et al.
Publicado: (2014)

Low level HIV viremia is more frequent under protease-inhibitor containing firstline therapy than under NNRTI-regimens
por: Wiesmann, Frank, et al.
Publicado: (2014)

Effect of HIV infection-related factors on SVR rate in HCV treatment in HIV-infected patients
por: Kravchenko, Alexey, et al.
Publicado: (2014)

Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment
por: Ehret, Robert, et al.
Publicado: (2014)

Recreational drugs and HIV in Europe: current use of recreational drugs and principal HIV guidelines related recommendations
por: Garin Escriva, Noe, et al.
Publicado: (2014)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

Liver Fibrosis progression using Fibroscan in HIV/HCV coinfected patients with undetectable HIV viral load
por: Perez-Martinez, Laura, et al.
Publicado: (2014)

Targeted destruction of HIV-positive cells
por: Sharma, Jyoti R, et al.
Publicado: (2014)

Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
por: Meixenberger, Karolin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o04cvmhf7ki7ihondk2qv173uq